Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: We are waiting for the delegation from WHO to present the substances. I have the pleasure to invite Mr, to present substances: N-pyrrolidino isotonitazene and N-desethyl etonitazene to be placed in.Schedule I from the single …
Kenya
Side event: Principles on drug treatment as alternatives to conviction or punishment
Candice Welsh, UNODC. Drug use conditions are health issues. Scientific evidence based treatment improves health outcomes and benefits communities in multiple ways. Alternatives to incarceration are in line to international drug conventions and improve health, wellbeing and public safety. In 2015, UNODC launched its first handbook on the subject. This is where the implementation principles …
CND Thematic Discussions on the Implementation of All International Drug Policy Commitments, following-up to the 2019 Ministerial Declaration – 30 September 2025 – Afternoon Session
CND Thematic Discussions on Strengthening Public Health Responses to Drug Use Session 2: Drug Treatment and Health Services Falling Short of Meeting Needs; Increase in Deaths Related to Drug Use Chair: We begin the afternoon session with a discussion on the topic of Treatment and health services – falling short of meeting needs, increase in deaths …
Plenary — Wednesday morning session
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …
Plenary — Tuesday afternoon session
Item 4. Strategic management, budgetary and administrative questions China: The Chinese government has consistently supported and actively participated in drug control efforts advocated by UNODC. UNODC has played an important role in supporting member states and taking measures to address the drug problems and provide technical assistance. China appreciates the positive efforts and results seen …
CND Intersessional – Session 1 – Expanding range of drugs and synthetic opioids and nonmedical use of prescription drugs
CND Intersessional meeting – Thematic discussions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration Secretariat: (administrative and organizational issues) Chair: Welcome. The topics of the three days of this meeting are identified in the 2019 declaration. One of the challenges is the funding and diversification of drug …